Fundraising Fox

Anthony DePasqua

Founder

Founder at EnClear Therapies

Newburyport, Massachusetts, United States

FoundedEnClear Therapies

About

Anthony DePasqua is President & CEO and a board director at EnClear Therapies, which is developing a cerebrospinal fluid access platform for targeted delivery of therapies to the brain. He has more than 20 years of experience leading venture-backed and business-unit MedTech, HealthTech, and Life Sciences organizations across neurotechnology, oncology, spine, orthopedics, and surgical platforms, and previously co-founded and served as CEO of a neurotechnology company. His background includes generating over $200 million in early-stage and growth revenue, raising more than $20 million in venture capital along with strategic R&D partnerships and NIH grant funding, and managing R&D budgets and commercialization programs.

Founder at EnClear Therapies

Intro paths

→

In turn, Anthony can intro founders to EnClear Therapies's investors below.

EnClear Therapies's investors · 5

20/20 HealthCare Partners LLCAuburndale · since 2024Dolby Family VenturesSan Francisco · since 2024Flucas VenturesJupiter · $100K – $5M checks · since 2024Tachyon VenturesLos Angeles · since 2024VU Venture PartnersSan Francisco · $200K – $1M checks · since 2024

Experience

  1. EnClear TherapiesPresident & CEO | Board Directorcurrent2018 — presentCambridge, MA
  2. Aperçu DiagnosticsBoard Directorcurrent2021 — presentBoston, MA
  3. MedtronicHead of Portfolio Strategy & BU Business Development2015 — 2018Portsmouth, NH
  4. MedtronicHead of Strategy2015 — 2018
  5. MedtronicHead of Upstream Marketing2011 — 2015Portsmouth NH
  6. MedtronicHead of Marketing2011 — 2015
  7. MedtronicProduct/Marketing Manager2008 — 2011Portsmouth, NH
  8. MedtronicProduct Marketing Manager2008 — 2011
  9. Ward Hill MarketingProgram Manager2006 — 2007
  10. HydroCisionProduct Manager2004 — 2005
  11. MISTsoft CorpMarketing and Sales Director2004
  12. Northeastern UniversityFulltime MBA student2002 — 2003
  13. Harvest Technologies, IncRegional Sales Manager2000 — 2002
  14. Comsol, IncMarketing Assistant2000

Skills & more

LaunchesBrand MarketingDue DiligenceDeal ExecutionStaff AugmentationTransparencyResearch and Development (R&D)Operational ExcellenceLarge ProjectsFinancial LiteracyGrowth StrategiesGeneral Management
+12 morePersuasionNew LeadsProduct LeadershipRegional MarketingInvestment DecisionsFuture TrendsExecutive Presentation SkillsValue CreationVice PresidentsStrategic GrowthSales EffectivenessRedesigning

From Anthony's professional profile.

Frequently asked questions

Who is Anthony DePasqua?
Anthony DePasqua is President & CEO and a board director at EnClear Therapies, which is developing a cerebrospinal fluid access platform for targeted delivery of therapies to the brain. He has more than 20 years of experience leading venture-backed and business-unit MedTech, HealthTech, and Life Sciences organizations across neurotechnology, oncology, spine, orthopedics, and surgical platforms, and previously co-founded and served as CEO of a neurotechnology company. His background includes generating over $200 million in early-stage and growth revenue, raising more than $20 million in venture capital along with strategic R&D partnerships and NIH grant funding, and managing R&D budgets and commercialization programs.
Where does Anthony DePasqua work?
Anthony DePasqua is Founder of EnClear Therapies.
What companies did Anthony DePasqua found?
Anthony DePasqua founded EnClear Therapies.
Where did Anthony DePasqua go to school?
Anthony DePasqua studied at D'Amore-McKim School of Business at Northeastern University (MBA, Business Admin/Marketing); Salve Regina University (BA, Business Administration); Northeastern University (Master of Business Administration, Marketing).

Same school

Also attended D'Amore-McKim School of Business at Northeastern University36

Bruce SachsInvestor at CRV (Charles River Ventures)Kerry HullChief Financial Officer & Chief Operating Officer at CincyTechNicholas AdamsManaging Partner at Differential VenturesChristian DesmarteauxDirector of Investor Relations at MPM BioImpactElaine SunInvestor at CapitalGGretchen McCareyChief Financial Officer at Castle Island Ventures

+ 30 more

Also attended Salve Regina University6

Zach MakoskeAssociate at Bienville CapitalKhushbu ModiExecutive Assistant at Broadview VenturesAndrew HallVenture Partner at Iter InvestmentsAshley LanglaisChief of Staff at DVx VenturesEd WuCo-Founder & Chief Innovation Officer at SideMichael TrueCo-founder at Prescient

Also attended Northeastern University320

Matt GuineyChief Financial Officer at Flybridge Capital PartnersAzamat GasanovAssociate at Marlin Equity PartnersSaunaz MoradiPartner, Communications at Lux CapitalBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Arjun BalajiPartner, Investing & Research at Paradigm

+ 314 more

Shared employers

Also worked at EnClear Therapies1

Doug HicksEntrepreneur-In-Residence at The Innovation Space

Also worked at Medtronic91

Paul SlosarInvestor at FortySix Venture CapitalJay W. SchmelterCo-founder of RiverVest Venture Partners, funding and founding life science companiesAshley ArchibequeExecutive Assistant at Two Bear CapitalDavid RodriguezInvestor at Draft Ventures LlcEvan PritchardSenior Managing Director & Co-Founder at JStar Capital InvestmentsAzin ParhizgarManaging Director, US at 415 Capital

+ 85 more

Also worked at Northeastern University66

Kerry HullChief Financial Officer & Chief Operating Officer at CincyTechWilliam WooImpact at Non Sibi VenturesToshihiro TeradaInvestor at E12 Venture Capital, LlcPaula AndreuInvestor at KfundVashegaarie SundarInvestor Relations Associate at FusionJanvi PatelInvestment Committee at ALIAVIA Ventures

+ 60 more